Fidelity Investments’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,390
| Closed | -$518K | – | 5204 |
|
|
2021
Q1 | $518K | Buy |
2,390
+2,387
| +79,567% | +$449K | ﹤0.01% | 2681 |
|
|
2020
Q4 | $0 | Sell |
3
-5,054
| -100% | -$566K | ﹤0.01% | 4456 |
|
|
2020
Q3 | $493K | Sell |
5,057
-9,304
| -65% | -$1.07M | ﹤0.01% | 2536 |
|
|
2020
Q2 | $1.76M | Sell |
14,361
-72,466
| -83% | -$8.22M | ﹤0.01% | 2302 |
|
|
2020
Q1 | $7.6M | Sell |
86,827
-92
| -0.1% | -$9.74K | ﹤0.01% | 1780 |
|
|
2019
Q4 | $9.09M | Buy |
86,919
+57,960
| +200% | +$6.5M | ﹤0.01% | 1882 |
|
|
2019
Q3 | $3.33M | Sell |
28,959
-116,163
| -80% | -$17.6M | ﹤0.01% | 2150 |
|
|
2019
Q2 | $25M | Buy |
145,122
+10,440
| +8% | +$1.81M | ﹤0.01% | 1527 |
|
|
2019
Q1 | $22.7M | Buy |
134,682
+134,155
| +25,456% | +$20M | ﹤0.01% | 1553 |
|
|
2018
Q4 | $51K | Sell |
527
-103,993
| -99% | -$13.6M | ﹤0.01% | 2726 |
|
|
2018
Q3 | $18.1M | Buy |
104,520
+40,044
| +62% | +$5.77M | ﹤0.01% | 1718 |
|
|
2018
Q2 | $9M | Sell |
64,476
-310,193
| -83% | -$44.1M | ﹤0.01% | 1979 |
|
|
2018
Q1 | $42.2M | Sell |
374,669
-329,436
| -47% | -$41.4M | 0.01% | 1382 |
|
|
2017
Q4 | $92.9M | Sell |
704,105
-205,522
| -23% | -$24.1M | 0.01% | 1032 |
|
|
2017
Q3 | $92.3M | Sell |
909,627
-243,900
| -21% | -$26.1M | 0.01% | 1005 |
|
|
2017
Q2 | $116M | Sell |
1,153,527
-345,388
| -23% | -$37.2M | 0.01% | 910 |
|
|
2017
Q1 | $181M | Sell |
1,498,915
-216,350
| -13% | -$26.5M | 0.02% | 727 |
|
|
2016
Q4 | $192M | Sell |
1,715,265
-39,593
| -2% | -$4.77M | 0.03% | 689 |
|
|
2016
Q3 | $233M | Buy |
1,754,858
+155,110
| +10% | +$14.8M | 0.03% | 601 |
|
|
2016
Q2 | $146M | Sell |
1,599,748
-256,180
| -14% | -$21.6M | 0.02% | 799 |
|
|
2016
Q1 | $134M | Sell |
1,855,928
-320,571
| -15% | -$17.6M | 0.02% | 847 |
|
|
2015
Q4 | $151M | Hold |
2,176,499
| – | – | 0.02% | 777 |
|
|
2015
Q3 | $199M | Buy |
2,176,499
+12,652
| +0.6% | +$1.41M | 0.03% | 638 |
|
|
2015
Q2 | $266M | Buy |
2,163,847
+477,712
| +28% | +$54.2M | 0.03% | 554 |
|
|
2015
Q1 | $154M | Buy |
1,686,135
+996,508
| +144% | +$80.9M | 0.02% | 823 |
|
|
2014
Q4 | $46.7M | Buy |
689,627
+151,700
| +28% | +$11.1M | 0.01% | 1352 |
|
|
2014
Q3 | $43.5M | Sell |
537,927
-233,000
| -30% | -$20.6M | 0.01% | 1360 |
|
|
2014
Q2 | $82.7M | Sell |
770,927
-36,900
| -5% | -$2.57M | 0.01% | 1111 |
|
|
2014
Q1 | $48M | Buy |
807,827
+372,600
| +86% | +$22.2M | 0.01% | 1342 |
|
|
2013
Q4 | $18.1M | Buy |
+435,227
| New | +$13.8M | ﹤0.01% | 1753 |
|
Other funds holding GWPH
Fidelity Investments's GWPH Position: Q2 2021 in Review
Fidelity Investments sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 2,390 shares — an estimated $518K sold.
Fidelity Investments first reported a position in GWPH in Q4 2013 and held it in 30 quarters. The position peaked at $266M in Q2 2015. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Fidelity Investments reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Fidelity Investments sold 2,390 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $518K.
- Fidelity Investments first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 30 quarters.
- Fidelity Investments's GW Pharmaceuticals Plc American Depositary Shares position peaked at $266M in Q2 2015.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Fidelity Investments's 13F filing for Q2 2021, filed 13 Aug 2021.